Clinical Trial

Latin American Testing of the Inventory for Risk in Suicidal Crisis Syndrome (LATIR-SCS)

Study acronym: LATIR-SCS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational validation study is to assess the psychometric properties of the Spanish versions of the Suicide Crisis Inventory-Revised (SCS-2) and the Suicidal Crisis Syndrome Checklist (SCS-C) in adults recently hospitalized for suicidal behavior in Chile. The study aims to determine whether the Spanish versions of the SCS-2 and SCS-C demonstrate adequate internal consistency, construct validity, interrater reliability, and test-retest stability, and whether these tools validly assess imminent suicide risk in a Spanish-speaking psychiatric population. Clinical assessments using the SCS-2 and SCS-C will be compared with established diagnostic and functional measures, including the Mini International Neuropsychiatric Interview (MINI), the Sheehan Disability Scale (SDS), and the Sheehan Suicidality Tracking Scale (S-STS), to evaluate convergent and discriminant validity. Participants will complete the SCS-2 and SCS-C at both admission and discharge from a psychiatric intensive care unit, undergo structured interviews and functional assessments, be evaluated by two independent raters for interrater reliability, and be reassessed within a short time interval to measure test-retest reliability. Follow-up contacts at 7 and 30 days post-discharge will be used to assess suicidal behavior outcomes. This is the first study to culturally adapt and validate these suicide-specific instruments in Latin America.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2025-09-15
Trial Details
NCT Number NCT07103850
Lead Sponsor University Diego Portales
Collaborators: Hospital Dr Sotero del Rio
Conditions Suicidal Crisis
Enrollment 60 participants
Start Date 2025-08-12
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-19